Literature DB >> 8217972

Antiphospholipid antibodies in pregnancy: prevalence and clinical associations.

N S Pattison1, L W Chamley, E J McKay, G C Liggins, W S Butler.   

Abstract

OBJECTIVE: To determine prevalence, clinical association and predictive power of antiphospholipid antibodies in pregnancy.
DESIGN: To test for the presence of anticardiolipin antibodies and lupus anticoagulant in order to confirm prevalence data which imply that each antibody has the same clinical significance. A detailed obstetric history and the outcome measures were obtained from each patient in the study.
SETTING: National Women's Hospital, Auckland, New Zealand.
SUBJECTS: Nine hundred and thirty-three consecutively booked pregnant women. MAIN OUTCOME MEASURES: Prevalence of auto-antibodies; perinatal morbidity and mortality; incidence of pre-eclampsia, growth retardation and fetal distress.
RESULTS: Nine women (1.0%) had anticardiolipin antibodies, 11 (1.2%) had lupus anticoagulant and two had both antibodies. The fetal mortality rate for women with antibodies was 167/1000. Pre-eclampsia occurred significantly more often in women with auto-antibodies.
CONCLUSION: The presence of antiphospholipid antibodies is frequently associated with adverse pregnancy outcome (9/18 pregnancies). High titre anticardiolipin antibodies carry a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8217972     DOI: 10.1111/j.1471-0528.1993.tb15105.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  15 in total

Review 1.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies.

Authors:  Kirsten Duckitt; Deborah Harrington
Journal:  BMJ       Date:  2005-03-02

2.  Antiphospholipid antibodies in women with severe preeclampsia and placental insufficiency: a case-control study.

Authors:  K J Gibbins; A E Tebo; S K Nielsen; D W Branch
Journal:  Lupus       Date:  2018-07-20       Impact factor: 2.911

3.  Antiphospholipid Syndrome during pregnancy: the state of the art.

Authors:  Fosca A F Di Prima; Oriana Valenti; Entela Hyseni; Elsa Giorgio; Marianna Faraci; Eliana Renda; Roberta De Domenico; Santo Monte
Journal:  J Prenat Med       Date:  2011-04

4.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

5.  Conformationally altered beta 2-glycoprotein I is the antigen for anti-cardiolipin autoantibodies.

Authors:  L W Chamley; A M Duncalf; B Konarkowska; M D Mitchell; P M Johnson
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

6.  Neonatal lupus syndrome: a case with chondrodysplasia punctata and other unusual manifestations.

Authors:  E Austin-Ward; S Castillo; M Cuchacovich; A Espinoza; J Cofré-Beca; S González; X Solivelles; J Bloomfield
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

Review 7.  Duration of anticoagulation treatment for thrombosis in APS: is it ever safe to stop?

Authors:  Sinthiya Punnialingam; Munther A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

8.  Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes.

Authors:  May Ching Soh; Dharmintra Pasupathy; Gabriella Gray; Catherine Nelson-Piercy
Journal:  Rheumatology (Oxford)       Date:  2013-05-16       Impact factor: 7.580

Review 9.  Work-up of stillbirth: a review of the evidence.

Authors:  Robert M Silver; Michael W Varner; Uma Reddy; Robert Goldenberg; Halit Pinar; Deborah Conway; Radek Bukowski; Marshall Carpenter; Carol Hogue; Marian Willinger; Donald Dudley; George Saade; Barbara Stoll
Journal:  Am J Obstet Gynecol       Date:  2007-05       Impact factor: 8.661

Review 10.  Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?

Authors:  Erin A S Clark; Robert M Silver; D Ware Branch
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.